Abstract
N-triethyl chitosan (TEC) has recently been proven to be an efficient polymer for improving transport of hydrophilic drugs. Thus, in order to evaluate its gene delivery efficiency, TEC is assembled with Enhanced Green fluorescence protein plasmid DNA (pEGFP) at different polymer to plasmid (N/P) ratios to form TEC/pEGFP nanoparticles. Photon correlation spectroscopy is used to evaluate nanoparticles size and zeta potential. The transfection efficiency and cytotoxicity in gene delivery to AsPC-1 cells (human pancreatic cancer cells) are evaluated via fluorescence microscopy, flow cytometry and MTT assay. Also parameters such as cancer cells’ mean fluorescence intensity (MFI) and cell size changes after transfection are assayed. The results indicate that the incorporation of pEGFP in TEC can form charged nanoparticles at N/P ratios from 10 to 40. Increasing the N/P ratio increases transfection efficiency, MFI, cell size and cytotoxicity. At N/P ratio of 10, transfection increased up to 11.12 fold with the least cytotoxicity. Considering that mathematical models can be used to understand and predict consequences associated with nanomedicine, the relation between TEC /pDNA nanoparticles charge ratio, cell transfection and toxicity was evaluated for the first time with interpolation polynomial method.
Keywords: N-triethyl chitosan, nanoparticles, AsPC-1 cells, gene delivery, transfection, cytotoxicity, mathematical models.
Drug Delivery Letters
Title:Evaluating Gene Delivery Using N-triethyl Chitosan Nanoparticles to AsPC-1 Cells and Predicting the Relation between Transfection, Cytotoxicity and Charge Ratio of Nanoparticles Via Mathematical Models
Volume: 3 Issue: 1
Author(s): S. Safari, F.A. Dorkoosh, M. Soleimani, M. H. Zarrintan, H. Akbari, B. Larijani and M. Rafiee Tehrani
Affiliation:
Keywords: N-triethyl chitosan, nanoparticles, AsPC-1 cells, gene delivery, transfection, cytotoxicity, mathematical models.
Abstract: N-triethyl chitosan (TEC) has recently been proven to be an efficient polymer for improving transport of hydrophilic drugs. Thus, in order to evaluate its gene delivery efficiency, TEC is assembled with Enhanced Green fluorescence protein plasmid DNA (pEGFP) at different polymer to plasmid (N/P) ratios to form TEC/pEGFP nanoparticles. Photon correlation spectroscopy is used to evaluate nanoparticles size and zeta potential. The transfection efficiency and cytotoxicity in gene delivery to AsPC-1 cells (human pancreatic cancer cells) are evaluated via fluorescence microscopy, flow cytometry and MTT assay. Also parameters such as cancer cells’ mean fluorescence intensity (MFI) and cell size changes after transfection are assayed. The results indicate that the incorporation of pEGFP in TEC can form charged nanoparticles at N/P ratios from 10 to 40. Increasing the N/P ratio increases transfection efficiency, MFI, cell size and cytotoxicity. At N/P ratio of 10, transfection increased up to 11.12 fold with the least cytotoxicity. Considering that mathematical models can be used to understand and predict consequences associated with nanomedicine, the relation between TEC /pDNA nanoparticles charge ratio, cell transfection and toxicity was evaluated for the first time with interpolation polynomial method.
Export Options
About this article
Cite this article as:
Safari S., Dorkoosh F.A., Soleimani M., Zarrintan M. H., Akbari H., Larijani B. and Tehrani M. Rafiee, Evaluating Gene Delivery Using N-triethyl Chitosan Nanoparticles to AsPC-1 Cells and Predicting the Relation between Transfection, Cytotoxicity and Charge Ratio of Nanoparticles Via Mathematical Models, Drug Delivery Letters 2013; 3 (1) . https://dx.doi.org/10.2174/2210304x11303010002
DOI https://dx.doi.org/10.2174/2210304x11303010002 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy Lactic Acid Bacteria and Lactic Acid for Skin Health and Melanogenesis Inhibition
Current Pharmaceutical Biotechnology Metabolomics as a Tool for Drug Discovery and Personalised Medicine. A Review
Current Topics in Medicinal Chemistry To Preliminarily Evaluate The Anticancer Activiy of 1,2-di(quinazolin-4- yl)diselane Against MDA-MB-435 Cells in vitro
Letters in Drug Design & Discovery 3-Carboranyl Thymidine Analogues (3CTAs) and Other Boronated Nucleosides for Boron Neutron Capture Therapy
Anti-Cancer Agents in Medicinal Chemistry SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Current Pharmaceutical Design Recent Advances in Intervention in Markovian Regulatory Networks
Current Genomics Editorial [Hot Topic: Cancer Biomarkers Guest Editor: Robert C. Rees]
Current Cancer Therapy Reviews Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Promising Strategies for Overcoming BRAF Inhibitor Resistance Based on Known Resistance Mechanisms
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design A Review on Metal Nanoparticles from Medicinal Plants: Synthesis, Characterization and Applications
Nanoscience & Nanotechnology-Asia Quality, not Quantity: The Role of Natural Products and Chemical Proteomics in Modern Drug Discovery
Combinatorial Chemistry & High Throughput Screening Regulation of Death and Growth Signals at the Plasma Membrane by Sphingomyelin Synthesis: Implications for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry Dendritic Cells and the Promise of Therapeutic Vaccines for Human Immunodeficiency Virus (HIV)-1
Current HIV Research Intracellular Delivery of Tumor Antigenic Peptides in Biodegradablepolymer Adjuvant for Enhancing Cancer Immunotherapy
Current Medicinal Chemistry AKT Signaling in Regulating Angiogenesis
Current Cancer Drug Targets A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry Revising Skin Cancers by Means of Epigenetic Markers
Recent Patents on Biomarkers